Carole Nicco

Dr. Carole Nicco

Université Paris Cité, Paris, Île-de-France, France
+1
orcid
BioSenic COO and CSO

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Blood
Verified
Journal Article
Closed access
PDF file
ESElodie Segura
Elodie Segura
Carole NiccoCarole Nicco
Carole Nicco
BLBérangère Lombard
Bérangère Lombard
PVPhilippe Véron
Philippe Véron
GRGraça Raposo
Graça Raposo
CTClotilde Théry
Clotilde Théry
Exosomes are secreted vesicles formed in late endocytic compartments. Immature dendritic cells (DCs) secrete exosomes, which transfer functional major histocompatibility complex (MHC)–peptide complexes to other DCs. Since immature and mature DCs induce different functional T-cell responses (ie, tolerance versus priming), we asked whether DC maturation also influenced the priming abilities of their exosomes. We show that exosomes secreted by lipopolysaccharide (LPS)–treated mature DCs are 50- to 100-fold more potent to induce antigen-specific T-cell activation in vitro than exosomes from immature DCs. In vitro, exosomes from mature DCs transfer to B lymphocytes the ability to prime naive T cells. In vivo, only mature exosomes trigger effector T-cell responses, leading to fast skin graft rejection. Proteomic and biochemical analyses revealed that mature exosomes are enriched in MHC class II, B7.2, intercellular adhesion molecule 1 (ICAM-1), and bear little milk-fat globule–epidermal growth factor–factor VIII (MFG-E8) as compared with immature exosomes. Functional analysis using DC-derived exosomes from knock-out mice showed that MHC class II and ICAM-1 are required for mature exosomes to prime naive T cells, whereas B7.2 and MFG-E8 are dispensable. Therefore, changes in protein composition and priming abilities of exosomes reflect the maturation signals received by DCs.

1 February 2005 in Cancer Research
Verified
Journal Article
Open access
PDF file
ALAlexis Laurent
Alexis Laurent
Carole NiccoCarole Nicco
Carole Nicco
CCChristiane Chéreau
Christiane Chéreau
CGClaire Goulvestre
Claire Goulvestre
JAJérôme Alexandre
Jérôme Alexandre
FBFrederic Batteux
Frederic Batteux
Paradoxically, reactive oxygen species (ROS) can promote normal cellular proliferation and carcinogenesis, and can also induce apoptosis of tumor cells. In this report, we study the contribution of ROS to various cellular signals depending on the nature and the level of ROS produced. In nontransformed NIH 3T3 cells, ROS are at low levels and originate from NADPH oxidase. Hydrogen peroxide (H2O2), controlled by the glutathione system, is pivotal for the modulation of normal cell proliferation. In CT26 (colon) and Hepa 1-6 (liver) tumor cells, high levels of ROS, close to the threshold of cytotoxicity, are produced by mitochondria and H2O2 is controlled by catalase. N-acetylcysteine, which decreases H2O2 levels, inhibits mitogen-activated protein kinase and normal cell proliferation but increases tumor cell proliferation as H2O2 concentration drops from the toxicity threshold. In contrast, antioxidant molecules, such as mimics of superoxide dismutase (SOD), increase H2O2 levels through superoxide anion dismutation, as well as in vitro proliferation of normal cells, but kill tumor cells. CT26 tumors were implanted in mice and treated by oxaliplatin in association with one of the three SOD mimics manganese(III)tetrakis(4-benzoic acid) porphyrin, copper(II)(3,5-diisopropylsalicylate)2, or manganese dipyridoxyl diphosphate. After 1 month, the volumes of tumors were respectively 35%, 31%, and 63% smaller than with oxaliplatin alone (P < 0.001). Similar data were gained with Hepa 1-6 tumors. In conclusion, antioxidant molecules may have opposite effects on tumor growth. SOD mimics can act in synergy with cytotoxic drugs to treat colon and liver cancers.

7 March 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
PGPrisca Gebrayel
Prisca Gebrayel
Carole NiccoCarole Nicco
Carole Nicco
SKSouhaila Al Khodor
Souhaila Al Khodor
JBJaroslaw Bilinski
Jaroslaw Bilinski
ECElisabetta Caselli
Elisabetta Caselli
MEMarvin Edeas
Marvin Edeas
The human gastrointestinal tract is inhabited by the largest microbial community within the human body consisting of trillions of microbes called gut microbiota. The normal flora is the site of many physiological functions such as enhancing the host immunity, participating in the nutrient absorption and protecting the body against pathogenic microorganisms. Numerous investigations showed a bidirectional interplay between gut microbiota and many organs within the human body such as the intestines, the lungs, the brain, and the skin. Large body of evidence demonstrated, more than a decade ago, that the gut microbial alteration is a key factor in the pathogenesis of many local and systemic disorders. In this regard, a deep understanding of the mechanisms involved in the gut microbial symbiosis/dysbiosis is crucial for the clinical and health field. We review the most recent studies on the involvement of gut microbiota in the pathogenesis of many diseases. We also elaborate the different strategies used to manipulate the gut microbiota in the prevention and treatment of disorders. The future of medicine is strongly related to the quality of our microbiota. Targeting microbiota dysbiosis will be a huge challenge.

17 April 2006 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
JAJérôme Alexandre
Jérôme Alexandre
FBFrederic Batteux
Frederic Batteux
Carole NiccoCarole Nicco
Carole Nicco
CCChristiane Chéreau
Christiane Chéreau
ALAlexis Laurent
Alexis Laurent
FGFrançois Goldwasser
François Goldwasser
Intracellular events following paclitaxel binding to microtubules that lead to cell death remain poorly understood. Because reactive oxygen species (ROS) are involved in the cytotoxicity of anticancer agents acting through independent molecular targets, we explored the role of ROS in paclitaxel cytotoxicity. Within 15 min after in vitro exposure of A549 human lung cancer cells to paclitaxel, a concentration‐dependent intracellular increase in O°2− and H2O2 levels was detected by spectrofluorometry. Addition of N‐acetylcysteine (NAC) or glutathione, two H2O2 scavenger, induced a 4‐fold increase in paclitaxel IC50. Delaying NAC co‐incubation by 4 hr, resulted in a 3‐fold reduction in cell protection. The glutathione synthesis inhibitor, buthionine sulfoximine significantly increased paclitaxel cytotoxicity and H2O2 accumulation, but did not modify O°2− levels. Co‐incubation with diphenylene iodonium suggested that paclitaxel induced‐O°2− production was in part associated with increased activity of cytoplasmic NADPH oxidase. Concomitant treatment with inhibitors of caspases 3 and 8 increased cell survival but did not prevent the early accumulation of H2O2. To evaluate the role of ROS in paclitaxel antitumoral activity, mice were injected with LLC1 lung cancer cells and treated with paclitaxel i.p. and/or NAC. The antitumoral activity of paclitaxel in mice was abolished by NAC. In conclusion, the accumulation of H2O2 is an early and crucial step for paclitaxel‐induced cancer cell death before the commitment of the cells into apoptosis. These results suggest that ROS participate in vitro and in vivo to paclitaxel cytotoxicity.

1 July 2009 in The American Journal of Pathology
Verified
Journal Article
Closed access
CNCharlotte Ngô
Charlotte Ngô
CCChristiane Chéreau
Christiane Chéreau
Carole NiccoCarole Nicco
Carole Nicco
BWBernard Weill
Bernard Weill
CCCharles Chapron
Charles Chapron
FBFrederic Batteux
Frederic Batteux

1 September 2010 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
PDPierre Duffau
Pierre Duffau
JSJulien Seneschal
Julien Seneschal
Carole NiccoCarole Nicco
Carole Nicco
CRChristophe Richez
Christophe Richez
ELEstibaliz Lazaro
Estibaliz Lazaro
PBPatrick Blanco
Patrick Blanco
In the autoimmune disease lupus, platelets activated by self-antigens contribute to pathology by triggering the secretion of interferon from immune cells.